New test set to improve care for patients with suspected heart attack

May 2, 2014 by Emma Smith

Manchester researchers have developed a novel approach, called the Manchester Acute Coronary Syndromes Decision Rule, to more quickly and effectively diagnose heart attack in patients admitted to emergency departments.

Chest pain is the most common reason for emergency hospital admission. In Manchester, the incidence of premature death due to heart disease and stroke is amongst the highest in England. The rule has the potential to safely reduce unnecessary hospital admissions, and more appropriately allocate time and resource to who need help most.

The study published today in the international, peer-reviewed medical journal, Heart, indicates that using the simple decision rule will help doctors to make more accurate decisions based on a patient's symptoms and the results of simple blood tests. This could reduce the need for patients to be unnecessarily admitted to hospital for further tests, and rapidly identify the highest risk patients, so that they can receive appropriate treatments more quickly.

The researchers from Manchester Royal Infirmary, Stockport NHS Foundation Trust, The University of Manchester, and Manchester Metropolitan University, discovered that the decision rule could allow more than one in four patients with to be safely and immediately discharged from the . In contrast, the decision rule also accurately classifies around one in ten patients with chest pain as 'high risk', enabling them to receive more intensive treatment at an early stage and to be treated in a specialist area such as a coronary care unit.

Clinicians have been using the results of blood tests to detect heart attacks for some time. The most widely used test, which detects a protein called troponin, can identify nine out of ten heart attacks when patients first arrive in the emergency department. However, it can take several hours for troponin levels to rise in the blood after a , which means that many patients are admitted to hospital to wait for later tests. Most of these later tests show normal results, so the availability of an accurate test that can be undertaken earlier in the process has the potential to avoid many unnecessary hospital admissions.

The decision rule combines the results of the first troponin test with levels of another protein that may detect earlier signs of heart damage: heart-type fatty acid binding protein. It also takes into account a patient's symptoms and the findings from the electrocardiogram (ECG), which shows the flow of electricity through the heart. Using a simple computer program, doctors can determine from the decision rule the chance that a patient is having a heart attack. This research found that none of the patients who were identified by the decision rule as being safe to discharge from the emergency department had a heart attack. In contrast, over 95 per cent of the patients in the 'high risk' category had a heart problem.

Dr Rick Body, Consultant in Emergency Medicine at Manchester Royal Infirmary and Honorary Lecturer in Cardiovascular Medicine at The University of Manchester, who led the study said, "This study could potentially make a huge difference to the way we diagnose attacks and the subsequent treatment options for our patients.

We have now tested the accuracy of the rule in more than 1100 patients by observing what could have happened if we'd have used the decision rule instead of providing our routine care. This study provides the safety and effectiveness evidence required for us to start using the decision rule to guide patient care. In the next phase of our work we will carefully study the potential benefits of the decision rule for both patients and the NHS".

Explore further: Blood test helps predict heart attack risk for patients with chest pain

More information: "The Manchester Acute Coronary Syndromes (MACS) decision rule for suspected cardiac chest pain: derivation and external validation." Richard Body, Simon Carley, Garry McDowell, Philip Pemberton, Gillian Burrows, Gary Cook, Philip S Lewis, Alexander Smith, Kevin Mackway-Jones. Heart heartjnl-2014-305564Published Online First: 29 April 2014 DOI: 10.1136/heartjnl-2014-305564

Related Stories

Blood test helps predict heart attack risk for patients with chest pain

March 31, 2014
Patients presenting to the emergency department with an undetectable level of the blood biomarker high-sensitivity cardiac troponin T, and whose ECGs show no sign of restricted blood flow, have a minimal risk of heart attack ...

Test accurately rules out heart attacks in the ER (Update)

March 30, 2014
A simple test appears very good at ruling out heart attacks in people who go to emergency rooms with chest pain, a big public health issue and a huge worry for patients.

Manchester patients take part in pioneering heart attack blood test trial

February 27, 2013
High levels of a chemical called troponin in the blood can indicate a heart attack. A new, highly sensitive blood test for troponin will be used on blood samples donated by 140 patients who were admitted to MRI with chest ...

New blood test could detect heart attacks more quickly

February 25, 2014
A new blood test can detect heart attacks hours faster than the current gold-standard blood test, according to a study led by Loyola University Chicago Stritch School of Medicine researchers.

Simple test in the ambulance saves lives after heart attack, new study finds

April 14, 2014
A new study from the University of Surrey, published today in the journal Heart, has identified a positive link between the survival of heart attack patients and the use of an electrocardiogram (ECG), by ambulance crews.

New method quickly determines if chest pain is acute coronary syndrome

November 5, 2013
Researchers at Karolinska Institutet have tested a new method for quickly ruling out acute myocardial infarction or other serious acute coronary disease in emergency department patients complaining of chest pains. The method, ...

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.